fda glp-1 warning letters october 2025 news issues 30 to online compounders FDA Issues Warning Letters Against
Description
While they both use semaglutide, theyre prescribed for different reasons and follow different dosing schedules
Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use these medications
Follow up if you do not receive confirmation within 48 hours
Table of Contents What Is Non-Alcoholic Fatty Liver Disease (NAFLD)
In this model, employees obtain GLP-1 prescriptions via eMeds telehealth platform (with remote monitoring), and then split the cost of the drugs with the employer at discounted rates
